Medical News

RSS

FDA grants approval for newest version of OnGuard Chest X-ray CAD technology

Riverain Medical announced today that the U.S. Food and Drug Administration has granted approval for the newest version of the OnGuard Chest X-ray Computer-Aided Detection technology. OnGuard identifies solitary pulmonary nodules that may represent early-stage lung cancer on an existing chest X-ray. This improved performance demonstrates a 73% reduction in false positive marks and 50% higher relative sensitivity compared to the original product.

22 Jun 2010

Pfizer announces voluntary withdrawal of Mylotarg from U.S. market following FDA request

Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.

22 Jun 2010

Semafore's SF1126 peptidic prodrug demonstrates clinical activity in chronic lymphocytic leukemia

Semafore Pharmaceuticals today announced the presentation of preliminary clinical data demonstrating that SF1126 has clinical activity in chronic lymphocytic leukemia (CLL). SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). The results were presented at Cambridge Healthtech Institute's 8th Annual Next-Gen Kinase Inhibitors Oncology & Beyond Conference being held June 21-23, 2010, in Cambridge, Massachusetts.

22 Jun 2010

Hunger hormone ghrelin heightens the appeal of high-calorie foods over low-calorie foods: Study

The "hunger" hormone ghrelin, which acts in the brain to stimulate hunger and increase food intake, heightens the appeal of high-calorie foods over low-calorie foods, according to a study that will be presented Tuesday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

Discoveries in study and manipulation of human ES cells win first prize in research competition

World-recognized discoveries in the study and manipulation of human embryonic stem cells have won first prize in a prestigious applied research competition for a Hebrew University of Jerusalem researcher.

22 Jun 2010

WHO issues comprehensive recommendations on children's medicines

The WHO on Friday issued "its first-ever guidance on how to use more than 240 essential medicines for children under 13," the Associated Press reports. "The data provide information on use, dosage and side effects of medicines as well as warnings about which children should not take them" and possible complications from interactions from drugs taken together, according to the WHO, the news service reports (6/19).

22 Jun 2010

Lexicon presents LX4211 Phase 2a clinical trial results for type 2 diabetes mellitus at ENDO 2010

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, presented clinical data and analysis from its Phase 2a clinical trial of LX4211 for patients with type 2 diabetes mellitus at ENDO 2010 today. The results reported today included newly-obtained data showing a trend of increased total GLP-1 in both LX4211 treatment arms relative to placebo as measured in a post-trial analysis of blood samples.

22 Jun 2010

USAID Administrator shares vision for agency reform

During a speech at the National Press Club on Friday, USAID Administrator Rajiv spoke about ongoing efforts to reform the agency he oversees, noting the importance of improving development strategies targeting women, among other things, All Headline News reports (6/20).

22 Jun 2010

Health leaders formally launch new strategy for polio eradication

Health leaders from around the world gathered on Friday to formally launch a new strategy for eradicating polio, Newsweek's "The Human Condition" blog reports in a post examining the challenges and successes health advocates face in attempting to wipe the virus out completely (Carmichael, 6/18).

22 Jun 2010

OrbusNeich's Genous Bio-engineered R stent shows safety for percutaneous treatment of coronary artery stenosis

OrbusNeich today announced that six-month clinical follow-up data show the safety and efficacy of the combination of pre-dilatation with a paclitaxel drug-eluting balloon (Sequent Please®, B.Braun) followed by implantation of the company's Genous Bio-engineered R stent for the percutaneous treatment of coronary artery stenosis.

22 Jun 2010

PPC Canada announces alliance with LifeSpeak

PPC Canada is pleased to announce an alliance with LifeSpeak Inc., designed to help customer employees across Canada work, learn and thrive. The addition of LifeSpeak's online, expert-led video clips to PPC Canada's current suite of offerings will provide employees with a just-in-time learning tool integrated into their Employee Assistance Program.

22 Jun 2010

NHLBI funds nine research grants to determine safety and efficacy of red blood cell transfusions

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, is funding nine research grants to determine if the safety and efficacy of red blood cell transfusions vary depending on how long the cells have been stored. One of the grants supports the first large, multi-center, randomized clinical trial to compare outcomes in heart surgery patients who receive transfusions of red blood cells that have been stored for shorter or longer amounts of time.

22 Jun 2010

Exposure to BPA in early life may affect testis function into adulthood

Exposure to environmental levels of the industrial chemical bisphenol A, or BPA, in the womb and early life may cause long-lasting harm to testicular function, according to a new study conducted in animals. The results are being presented Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

Tentative deal raises cigarette taxes in NY; Many Iowa hospitals close inpatient psychiatric units

Harvard Medical School, which has suffered financially due in part to a sharp decline in Harvard University's legendary endowment, has successfully negotiated a deal in which Boston's major teaching hospitals will contribute $36 million to the school over three years. The hospital money is a small portion of the medical school's $580 million annual budget, but it may represent a larger turning point in the unusual relationship between the country's top medical school and its prestigious hospital partners.

22 Jun 2010

EPA honors Merck and Codexis with Presidential Green Chemistry Challenge Award

Merck and Codexis, Inc. today announced that they have jointly been awarded the annual Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency for the development of a novel biocatalytic method for the synthesis of sitagliptin. In addition, a paper co-authored by Merck and Codexis scientists and published online June 17 in the peer-reviewed journal Science, details how an enzyme was systematically customized using Codexis technology to perform the key chemical step in the sitagliptin synthesis process.

22 Jun 2010

Louisiana becomes first state with a Democrat legislature to oppose requirement to purchase health insurance

Last Friday, June 18, 2010, Louisiana became the first state with a Democrat-controlled legislature to oppose a requirement to purchase health insurance—the centerpiece of President Barack Obama's health reform agenda. Louisiana House Bill 1474, which passed the Louisiana Senate with strong bipartisan support, will soon head to Gov. Bobby Jindal's desk. The measure is modeled after the American Legislative Exchange Council's Freedom of Choice in Health Care Act now introduced or announced in 42 states.

22 Jun 2010

Covidien International Finance prices $1.5 billion Senior Notes offering

Covidien plc today announced that its wholly-owned subsidiary, Covidien International Finance S.A. , priced an offering of $500 million aggregate principal amount of 1.875% senior notes due 2013, $400 million aggregate principal amount of 2.80% senior notes due 2015 and $600 million aggregate principal amount of 4.20% senior notes due 2020. The offering is expected to close on June 28, 2010.

22 Jun 2010

Number of uninsured grew by 3 million in 2009; Health safety net continues to fray

Help from the new health law may not come soon enough for many Americans, according to a report.

22 Jun 2010

DeCare Dental introduces International Emergency Dental Program

DeCare Dental, a global dental benefit management company and a wholly owned subsidiary of Anthem Blue Cross and Blue Shield in Missouri's parent company, is pleased to introduce the International Emergency Dental Program – a service that gives dental members and their covered dependents access to emergency dental care from credentialed dentists around the world.

22 Jun 2010

Cernostics, Geisinger announce personalized healthcare collaboration

Cernostics Inc., a biotechnology firm specializing in advanced cancer diagnostics, and Geisinger Health System, a $2.1 billion integrated health services organization, today announced a partnership in personalized healthcare. They will focus on developing diagnostic technologies to detect subtle differences in the cellular and molecular makeup of patient tissue samples. These technologies promise to more effectively predict disease progression and identify patients who are most likely to be receptive to specific cancer treatments.

22 Jun 2010

Medical News

FDA grants approval for newest version of OnGuard Chest X-ray CAD technology

Pfizer announces voluntary withdrawal of Mylotarg from U.S. market following FDA request

Semafore's SF1126 peptidic prodrug demonstrates clinical activity in chronic lymphocytic leukemia

Hunger hormone ghrelin heightens the appeal of high-calorie foods over low-calorie foods: Study

Discoveries in study and manipulation of human ES cells win first prize in research competition

WHO issues comprehensive recommendations on children's medicines

Lexicon presents LX4211 Phase 2a clinical trial results for type 2 diabetes mellitus at ENDO 2010

USAID Administrator shares vision for agency reform

Health leaders formally launch new strategy for polio eradication

OrbusNeich's Genous Bio-engineered R stent shows safety for percutaneous treatment of coronary artery stenosis

PPC Canada announces alliance with LifeSpeak

NHLBI funds nine research grants to determine safety and efficacy of red blood cell transfusions

Exposure to BPA in early life may affect testis function into adulthood

Tentative deal raises cigarette taxes in NY; Many Iowa hospitals close inpatient psychiatric units

EPA honors Merck and Codexis with Presidential Green Chemistry Challenge Award

Louisiana becomes first state with a Democrat legislature to oppose requirement to purchase health insurance

Covidien International Finance prices $1.5 billion Senior Notes offering

Number of uninsured grew by 3 million in 2009; Health safety net continues to fray

DeCare Dental introduces International Emergency Dental Program

Cernostics, Geisinger announce personalized healthcare collaboration

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News